Swiss American CDMO delivers break-through innovation and superior manufacturing solutions to global skin and wound care companies including cosmetic, OTC drug, and medical device regulatory pathways. For more than 30 years, Dallas-based Swiss-American has helped build popular brands using a unique blend of marketplace insight, scientific formulation and quality-driven lean manufacturing expertise. In 2007, Swiss-American developed and manufactured the widely recognized and physician-recommended, EltaMD® product line, which was divested in 2018.
“At our core, we’re problem-solvers,” said Komel Grover, president at Swiss-American. “Being flexible, innovative and customer-focused has been the focal point of our business for decades. This is why the products we develop and manufacture remain highly recommended within the medical community.”
Over the past decade, Swiss-American has been ranked twice as part of “Inc 5000,” Inc. Magazine’s annual list of the top 5,000 fast-growing, innovative U.S. companies.